A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Recently, a collaborative research team led by Professor Yong-Qiang Li of Shandong University and Professor Yanmei Yang of ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how a photodynamic nanohybrid system reverses hypoxia and augments anti-primary and metastatic tumor efficacy of ...

Current approved CAR T-cell therapy treatments rely on an ex vivo route, in which a patient’s T cells are removed, genetically engineered to target antigens, and put back into the patient. From ...

The FDA has reportedly put the director of its cell and gene therapy office on administrative leave and escorted her out of the agency.

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT has learned.

Nicole Verdun, top gene therapy regulator at the FDA, has been forced out of the agency.

Here's everything to know about the show 'Couples Therapy,' including if it's real, what it's like working with Dr. Orna Guralnik and where to watch.

Penn researchers believe new potential gene therapy for glioblastoma brain cancer offers ‘a lot of hope’ Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...

Mitomycin plus BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: A randomized phase 3 trial (ANZUP 1301).

ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC).